SEARCH

SEARCH BY CITATION

REFERENCES

  • 1)
    Sugimoto , Y. , Tsukahara , S. , Oh-hara , T. , Isoe , T. and Tsuruo , T. Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody . Cancer Res. , 50 , 69256930 ( 1990 ).
  • 2)
    Matsuo , K. , Kohno , K. , Takano , H. , Sato , S. , Kiue , A. and Kuwano , M. Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines . Cancer Res. , 50 , 59196824 ( 1990 ).
  • 3)
    Long , B. H. , Wang , L. , Lorico , A. , Wang , R. C. C. , Brattain , M. G. and Casazza , A. M. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines . Cancer Res. , 51 , 52755284 ( 1991 ).
  • 4)
    Kubota , N. , Nishio , K. , Takeda , Y. , Ohmori , T. , Funayama , Y. , Ogasawara , H. , Ohira , T. , Kunikake , H. , ter ashima , Y. and Saijo , N. Characterization of an etoposide-resistant human ovarian cancer cell line . Cancer Chemother. Pharmacol. , 34 , 183190 ( 1994 ).
  • 5)
    Tamura , H. , Kohchi , C. , Yamada , R. , Ikeda , T. , Koiwai , O. , Patterson , E. , Keene , D. J. , Okada , K. , Kjeidsen , E. , Nishikawa , K. and Andho , T. Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites . Nucleic Acids Res. , 19 , 6975 ( 1991 ).
  • 6)
    Kubota , N. , Kanzawa , F. , Nishio , K. , Takeda , Y. , Ohmori , T. , Fujiwara , Y. , ter ashima , Y. and Saijo , N. Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line . Biochem. Biophys. Res. Commun. , 188 , 571577 ( 1992 ).
  • 7)
    Bugg , B. Y. , Danks , M. K. , Beck , W. T. and Suttle , D. P. Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemia cells selected for resistance to teniposide . Proc. Natl. Acad. Sci. USA , 88 , 76547658 ( 1991 ).
  • 8)
    Minato , K. , Kanazawa , F. , Nishio , K. , Nakagawa , K. , Fujiwara , Y. and Saijo , N. Characterization of an etoposide-resistant human small-cell lung cancer cell line . Cancer Chemother. Pharmacol. , 26 , 313317 ( 1990 ).
  • 9)
    Kawato , Y. , Aonuma , M. , Hirota , Y. , Kuga , H. and Sato , K. Intracellular roles of SN-38, metabolite of the camp-tothecin derivative CPT-11, in the antitumor effect of CPT-11 . Cancer Res. , 51 , 41874191 ( 1991 ).
  • 10)
    Sugimoto , Y. , Tsukahara , S. , Oh-hara , T. , Liu , L. F. and Tsuruo , T. Elevated expression of DNA topoisomerase II in camptothecin-resistant human tumor cell lines . Cancer Res. , 50 , 79627965 ( 1990 ).
  • 11)
    Kim , R. , Hirabayashi , N. , Nishiyama , M. , Jinushi , K. , Toge , T. and Okada , K. Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice . Int. J. Cancer , 50 , 760766 ( 1992 ).
  • 12)
    Whitacre , C. M. , Zborowska , E. , Gohdon , N. H. , Mackay , W. and Berger , N. A. Topotecan increases topoisomerase II α levels and sensitivity to treatment with etoposide in schedule-dependent process . Cancer Res. , 57 , 14251428 ( 1997 ).
  • 13)
    Kano , Y. , Suzuki , K. , Akutsu , M. , Suda , K. , Inoue , Y. , Yoshida , M. , Sakamoto , S. and Miura , Y. Effects of CPT-11 in combination with other anti-cancer agent in culture . Int. J. Cancer , 50 , 604610 ( 1992 ).
  • 14)
    Bertrand , R. , O'Connor , P. M. , Kerrigan , D. and Pommier , Y. Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cells . Eur. J. Cancer , 28A, 743 , 748 ( 1992 ).
  • 15)
    Bonner , J. A. and Kozelsky , T. F. The significance of the sequence of administration of topotecan and etoposide . Cancer Chemother. Pharmacol. , 39 , 109112 ( 1996 ).
  • 16)
    Tolcher , A. W. A phase I study of topotecan (a topoisomerase I inhibitor) in combination with doxorubucin (a topoisomerase II inhibitor ). Proc. Am. Soc. Clin. Oncol. 13 , 422 ( 1994 ).
  • 17)
    Saijo , N. Clinical trials of irinotecan hydrochloride (CPT, campto injection, topotecan injection) in Japan . Ann. N.Y. Acad. Sci. , 803 , 292305 ( 1996 ).
  • 18)
    Utsugi , T. , Aoyagi , K. , Asao , T. , Okazaki , S. , Aoyagi , Y. , Sano , M. , Wierzba , K. and Yamada , Y. Antitumor activity of a novel quinoline derivative, TAS-103, with inhibitory effects on topoisomerase I and II . Jpn. J. Cancer Res. , 88 , 9921002 ( 1997 ).
  • 19)
    Skehan , P. , Storeng , R. , Scudiero , D. , Monks , A. , McMahon , J. , Vistica , D. , Warren , J. T. , Bokesch , H. , Kenney , S. and Boyd , M. R. New colorimetric cytotoxicity assay for anticancer-drug screening . J. Natl. Cancer Inst. 82 , 11071112 ( 1990 ).
  • 20)
    Saotome , T. , Morita , H. and Umeda , M. Cytotoxicity test with simplified crystal violet staining method using microtitre plates and its application to injection drugs . Toxic. in Vitro , 3 , 317321 ( 1989 ).
  • 21)
    Mosmann , T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays . J. Immunol. Methods , 65 , 5563 ( 1983 ).
  • 22)
    Zwelling , L. A. , Hinds , M. , Chan , D. , Mayes , J. , Sie , K. L. , Parker , E. , Silberman , L. , Redcliffe , A. , Beran , M. and Blick , M. Characterization of an amsacrine-resistant line of human leukemia cells . J. Biol. Chem. , 264 , 1641116420 ( 1989 ).
  • 23)
    Ozawa , S. , Sugiyama , Y. , Mitsuhashi , J. and Inaba , M. Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and Chinese hamster cells . Cancer Res. , 49 , 38233828 ( 1989 ).
  • 24)
    Inaba , M. , Mitsuhashi , J. , Kawada , S. and Nakano , H. Different modes of cell-killing action between DNA topoisomerase I and II inhibitors revealed by kinetic analysis . Jpn. J. Cancer Res. , 85 , 187193 ( 1994 ).
  • 25)
    Sone , S. , Ishii , K. and Tsuruo , T. Augmentation of 1-β-d-Arabinofuranosylcytosine resistance in human KB epidermoid carcinoma cells upon induction of a second resistance to vincristine . Cancer Res. , 46 , 30993104 ( 1986 ).
  • 26)
    Fairchild , C. R. , Ivy , S. P. , Kao-Shan , C. , Whang-Peng , J. , Rosen , M. , Israel , M. A. , Melera , P. W. , Cowan , K. H. and Goldsmith , M. E. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells . Cancer Res. , 47 , 51415148 ( 1987 ).
  • 27)
    Hong , W. S. , Saijo , S. , Sasaki , Y. , Minato , K. , Nakano , H. , Nakagawa , K. , Fujiwara , Y. , Nomura , K. and Twentyman , P. R. Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines . Int. J. Cancer , 41 , 46267 ( 1988 ).
  • 28)
    Bungo , M. , Fujiwara , Y. , Kasahara , K. , Nakagawa , K. , Ohe , Y. , Sasaki , Y. , Irino , S. and Saijo , N. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair . Cancer Res. , 50 , 25492553 ( 1990 ).
  • 29)
    Ohmori , T. , Morikage , T. , Sugimoto , Y. , Fujiwara , Y. , Kasahara , K. , Nishio , K. , Ohta , S. , Sasaki , Y. , Takahashi , T. and Saijo , N. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP) . Jpn. J. Cancer Res. , 84 , 8392 ( 1993 ).
  • 30)
    Johnston , P. G. , Drake , J. C. , Trepel , J. and Allegra , C. J. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines . Cancer Res. , 52 , 4306312 ( 1992 ).
  • 31)
    D'Arpa , P. , Beadmore , C. and Liu , L. E. Involvement of nucleic acid synthesis in cell killing mechanism of topo-isomerase poisons . Cancer Res. , 50 , 69196924 ( 1990 ).
  • 32)
    Hsiang , Y. , Lihou , M. G. and Liu , L. F. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin . Cancer Res. , 49 , 50775082 ( 1989 ).
  • 33)
    Roberge , M. , Th'ng , J. , Hamaguchi , J. and Bradbury , E. M. The topoisomerase II inhibitor VM-26 induces marked changes in histone H1 kinase activity, histone Hi and H3 phosphorylation, and chromosome condensation in G2 phase and mitotic BHK cells . J. Cell Biol. , 111 , 17531762 ( 1990 ).
  • 34)
    Taagepera , S. , Rao , P. N. , Drake , F. H. and Gorbsky , G. J. DNA topoisomerase IIα is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2 . Proc. Natl. Acad. Sci. USA , 90 , 84078411 ( 1993 ).
  • 35)
    Woessner , R. D. , Mattern , M. R. , Mirabelli , C. K. , Johnson , R. K. and Drake , F. H. Proliferation- and cell cycle-dependent differences in expression of the 170 kDa and 180 kDa forms of topoisomerase II in NIH-3T3 cells . Cell Growth Differ. , 2 , 209214 ( 1991 ).
  • 36)
    Prosperi , E. , Marchese , G. and Astaldi-Ricotti , G. C. B. Expression of the 170-kDa and 180-kDa isoforms of DNA topoisomerase II in resting and proliferating human lymphocytes . Cell Prolif. , 27 , 257267 ( 1994 ).
  • 37)
    Poot , M. , Hiller , K. H. , Heimpel , S. and Hoehn , H. Distinct patterns of cell cycle distribution elicited by compounds interfering with DNA topoisomerase I and II activity . Exp. Cell Res. , 218 , 326330 ( 1995 ).
  • 38)
    Bino , G. D. , Skierski , J. S. and Darzynkiewicz , Z. The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells . Exp. Cell Res. , 195 , 485491 ( 1991 ).
  • 39)
    Kaufmann , S. H. , Karp , J. E. , Jones , R. J. , Miller , C. B. , Schneider , E. , Zwelling , L. A. , Cowan , K. , Wendel , K. and Burke , P. J. Topoisomerase II level and drug sensitivity in adult acute myelogenous leukemia . Blood , 83 , 517530 ( 1994 ).
  • 40)
    Takatani , H. , Oka , M. , Fukuda , M. , Narasaki , F. , Nakano , R. , Ikeda , K. , ter ashi , K. , Kinoshita , A. , Soda , H. , Kanda , T. , Schneider , E. and Kohno , S. Gene mutation analysis and quantitation of DNA topoisomerase I in previously untreated non-small cell lung carcinomas . Jpn. J. Cancer Res. , 88 , 160165 ( 1997 ).